Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin.
The lipopeptidic antibiotic daptomycin is reported to reduce experimental tobramycin nephrotoxicity (D. Beauchamp, M. Pellerin, P. Gourde, M. Pettigrew and M. G. Bergeron, Antimicrob. Agents Chemother. 34:139-147, 1990; C. A. Wood, H. C. Finkbeiner, S. J. Kohlhepp, P. W. Kohnen, and D. C. Gilbert, A...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1994
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284536/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.742 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
